This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Genetics  • Genetic Disorders  • Hematology/ Hematologic Malignancies  • Leukemias/ Lymphomas  • Alert me on articles by topic  Social Bookmarking   What's this?

Yuri Pekarsky, PhD; Cora Hallas, PhD; Carlo M. Croce, MD

JAMA. 2001;286:2308-2314.

T-cell chronic lymphocytic/prolymphocytic leukemia (T-CLL/T-PLL) is a lymphoproliferative disease derived from immunocompetent post-thymic T cells. Activation (initiation of expression) of the TCL1 locus at chromosome 14q32.1 appears to be the causal event in the pathogenesis of these mature T-cell leukemias. This activation occurs as a result of translocations or inversions that cause rearrangement of the TCL1 (T-cell leukemia/lymphoma 1) locus with regulatory elements of T-cell receptor genes. To describe the molecular events that take part in the leukemogenesis of mature T-cell leukemias, we reviewed the literature and our own data on the molecular basis of mature T-cell leukemia. This data search revealed that 4 genes have been identified at the TCL1 locus: TCL1, TCL1b, TNG1, and TNG2. The expression of these genes is substantially increased following rearrangements involving 14q32.1. Functional analysis of the Tcl1 protein revealed its involvement in an Akt (protein kinase B) prosurvival pathway through its interaction with the Akt kinase, which promotes translocation of Akt to the nucleus and increases Akt's enzymatic activity. The available data provide important insights into the molecular mechanisms of T-cell leukemogenesis that may lead to the development of new drugs for treatment of mature T-cell leukemia.

Author Affiliations: Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pa.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

November 14, 2001
JAMA. 2001;286(18):2337-2338.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy
Nowak et al.
haematol 2009;94:518-527.
ABSTRACT | FULL TEXT  

A Novel Recurrent Chromosomal Inversion Implicates the Homeobox Gene Dlx5 in T-Cell Lymphomas from Lck-Akt2 Transgenic Mice
Tan et al.
Cancer Res. 2008;68:1296-1302.
ABSTRACT | FULL TEXT  

Proto-oncogene TCL1: more than just a coactivator for Akt
Noguchi et al.
FASEB J. 2007;21:2273-2284.
ABSTRACT | FULL TEXT  

T Cell Leukemia-1 Modulates TCR Signal Strength and IFN-{gamma} Levels through Phosphatidylinositol 3-Kinase and Protein Kinase C Pathway Activation
Hoyer et al.
J. Immunol. 2005;175:864-873.
ABSTRACT | FULL TEXT  

Structural Basis for the Co-activation of Protein Kinase B by T-cell Leukemia-1 (TCL1) Family Proto-oncoproteins
Auguin et al.
J. Biol. Chem. 2004;279:35890-35902.
ABSTRACT | FULL TEXT  

The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine
Wansa et al.
J. Biol. Chem. 2003;278:24776-24790.
ABSTRACT | FULL TEXT  

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin
Herling et al.
Blood 2003;101:5007-5009.
ABSTRACT | FULL TEXT  

Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma
Hoyer et al.
Proc. Natl. Acad. Sci. USA 2002;99:14392-14397.
ABSTRACT | FULL TEXT  

Genetics Moves Into the Medical Mainstream
Collins and Guttmacher
JAMA 2001;286:2322-2324.
FULL TEXT